Back

Sex-related disparities in the diagnosis of transthyretin cardiac amyloidosis (ATTR-CA) using technetium-pyrophosphate imaging (Tc-PYP)

12 May 2024 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure 2 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Samiksha Babbar

Peter Munk Cardiac Centre, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail
Factors of long-COVID symptoms 15-months post-recovery
Mrs K. Gryglewska-Wawrzak (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Factors associated with changes in fatigue in patients with heart failure
Professor T. Jaarsma (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
Subclinical congestion at discharge at patients admitted with acute decompensation of heart failure
Doctor M. Stratinaki (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: initial characteristics of the population, design and rationale of the ARCHER trial
Doctor C. Tschoepe (Berlin, DE)
Abstract Slides
Presentation thumbnail
Prognostic significance of mitral regurgitation in acute heart failure stratified by ejection fraction
Doctor R. Rajan (Kuwait City, KW)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure 2

The Event

Event poster

Heart Failure 2024

12 May 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Sex-differences from referral to tafamidis treatment outcomes in real-world patients with wild-type transthyretin amyloid cardiomyopathy.
thumbnail
Congress Presentation
Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort study
thumbnail
Congress Presentation
Gender differences in transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources